Robert E. Richie

778 total citations
38 papers, 589 citations indexed

About

Robert E. Richie is a scholar working on Surgery, Transplantation and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert E. Richie has authored 38 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 15 papers in Transplantation and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert E. Richie's work include Renal Transplantation Outcomes and Treatments (15 papers), Organ Transplantation Techniques and Outcomes (7 papers) and Renal and Vascular Pathologies (7 papers). Robert E. Richie is often cited by papers focused on Renal Transplantation Outcomes and Treatments (15 papers), Organ Transplantation Techniques and Outcomes (7 papers) and Renal and Vascular Pathologies (7 papers). Robert E. Richie collaborates with scholars based in United States. Robert E. Richie's co-authors include Robert C. MacDonell, Howard Johnson, William Nylander, John L. Sawyers, G Niblack, David H. Van Buren, J. Harold Helderman, Vernon Reynolds, George Holcomb and Bruce M. Smith and has published in prestigious journals such as Cancer, Annals of Surgery and Journal of the American Society of Nephrology.

In The Last Decade

Robert E. Richie

37 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert E. Richie United States 15 251 243 154 109 87 38 589
D Anaise United States 11 247 1.0× 191 0.8× 109 0.7× 121 1.1× 46 0.5× 58 531
A. Kostakis Greece 14 240 1.0× 276 1.1× 137 0.9× 113 1.0× 88 1.0× 33 612
G Sødal Norway 16 273 1.1× 200 0.8× 247 1.6× 256 2.3× 77 0.9× 63 650
B. Nolan United Kingdom 17 324 1.3× 292 1.2× 144 0.9× 138 1.3× 101 1.2× 33 734
F.J. Burgos Spain 14 199 0.8× 181 0.7× 154 1.0× 122 1.1× 85 1.0× 39 549
J Pascual Spain 15 239 1.0× 167 0.7× 107 0.7× 272 2.5× 128 1.5× 40 695
Andrea Buscaroli Italy 11 215 0.9× 157 0.6× 109 0.7× 158 1.4× 58 0.7× 58 573
Z Shapira Israel 15 269 1.1× 106 0.4× 59 0.4× 127 1.2× 154 1.8× 80 636
M. Zanazzi Italy 18 214 0.9× 199 0.8× 190 1.2× 225 2.1× 120 1.4× 69 911
Mark D. Odland United States 12 344 1.4× 159 0.7× 148 1.0× 74 0.7× 48 0.6× 26 611

Countries citing papers authored by Robert E. Richie

Since Specialization
Citations

This map shows the geographic impact of Robert E. Richie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Richie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Richie more than expected).

Fields of papers citing papers by Robert E. Richie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Richie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Richie. The network helps show where Robert E. Richie may publish in the future.

Co-authorship network of co-authors of Robert E. Richie

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Richie. A scholar is included among the top collaborators of Robert E. Richie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Richie. Robert E. Richie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buren, David Van, Jerita Payne, Sunil K. Geevarghese, et al.. (1998). Impact of sandimmune, neoral, and prograf on rejection incidence and renal function in primary liver transplant recipients. Transplantation Proceedings. 30(5). 1830–1832. 5 indexed citations
2.
Buren, David Van, Jerita Payne, Sunil K. Geevarghese, et al.. (1998). Renal Function in Primary Liver Transplant Recipients Receiving Neoral (Cyclosporine) Versus Prograf (Tacrolimus). Transplantation Proceedings. 30(4). 1401–1402. 9 indexed citations
3.
Becker, Bryan N., et al.. (1997). Care pathway reduces hospitalizations and cost for hemodialysis vascular access surgery. American Journal of Kidney Diseases. 30(4). 525–531. 21 indexed citations
4.
Dummer, J. Stephen, Michael O. Koch, David M. Gilliam, et al.. (1994). Disseminated Histoplasmosis Presenting as Urinary Tract Obstruction in a Renal Transplant Recipient. American Journal of Kidney Diseases. 23(4). 600–604. 18 indexed citations
5.
Buren, David Van, et al.. (1994). Cyclosporine improves results in HLA-identical sibling renal transplants.. PubMed. 26(5). 2514–5. 10 indexed citations
6.
McCune, Thomas R., William Nylander, David H. Van Buren, et al.. (1992). Colonic screening prior to renal transplantation and its impact on post‐transplant colonic complications. Clinical Transplantation. 6(2). 91–96. 26 indexed citations
7.
McCune, Thomas R., Howard Johnson, Robert C. MacDonell, et al.. (1992). The effect of polyimmune gammaglobulin for prophylaxis against reactivation cytomegalovirus infection in kidney and kidney/pancreas transplant recipients.. Journal of the American Society of Nephrology. 2(10). 1469–1474. 10 indexed citations
8.
Buren, David H. Van, et al.. (1991). Single-Center Analysis of Impact of Immunosuppressive Therapy Upon Renal Allograft Survival in the Black Population. Southern Medical Journal. 84(6). 715–718. 8 indexed citations
9.
Buren, David H. Van, Adedayo Adedoyin, Robert C. MacDonell, et al.. (1990). Effect of ciprofloxacin on cyclosporine pharmacokinetics.. PubMed. 50(5). 888–9. 13 indexed citations
10.
Johnson, Kaalan, G Niblack, Robert E. Richie, et al.. (1989). Multicenter comparison of rejection reversal: rabbit anti-human lymphocyte serum (ATS) versus horse anti-human lymphocyte globulin (ATGAM).. PubMed. 21(1 Pt 2). 1734–5. 7 indexed citations
11.
Tallent, Marion B., et al.. (1985). Neoplasia in Immunosuppressed Renal Transplant Patients: A 20-Year Experience. Southern Medical Journal. 78(5). 501–506. 12 indexed citations
12.
Smith, Bruce M., George Holcomb, Robert E. Richie, & Richard H. Dean. (1984). Renal Artery Dissection. Annals of Surgery. 200(2). 134–146. 33 indexed citations
13.
Richie, Robert E., et al.. (1983). Factors Influencing The Outcome Of Kidney Transplants. Annals of Surgery. 197(6). 672–677. 17 indexed citations
14.
Forbes, James T., et al.. (1981). Human natural cell-mediated cytotoxicity. Cancer Immunology Immunotherapy. 11(2). 139–145. 27 indexed citations
15.
Richie, Robert E., et al.. (1979). The Role of HLA Tissue Matching in Cadaveric Kidney Transplantation. Annals of Surgery. 189(5). 581–586. 3 indexed citations
16.
Richie, Robert E., et al.. (1977). New incision for renal transplantation. Urology. 9(4). 433–435. 2 indexed citations
17.
Richie, Robert E., Vernon Reynolds, & John L. Sawyers. (1973). Tumor Metastases to the Small Bowel from Extra-Abdominal Sites. Southern Medical Journal. 66(12). 1383–1387. 27 indexed citations
18.
Scott, H. William, Harrison Shull, James A. O’Neill, & Robert E. Richie. (1964). Experimental and Clinical Appraisal of Gastric Freezing for Duodenal Ulcer. Annals of Surgery. 159(5). 769–786. 14 indexed citations
19.
Byrd, Benjamin F., et al.. (1964). Surgical Operations for Peptic Ulcer in the Geriatric Patient. Annals of Surgery. 159(5). 787–793. 5 indexed citations
20.
McSwain, Barton, et al.. (1964). Malignant Melanoma. Annals of Surgery. 159(6). 967–975. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026